Labiana Health SA banner

Wall St Price Targets

LAB Price Forecast
Based on 3 analysts

+94% Upside
from €5 today

Labiana Health SA (LAB)’s 12-month stock price forecast through October 2027 has a consensus target of €9.69, implying 94% upside. The forecast is based on price targets from 3 Wall Street analysts.

LAB Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for LAB yet.

Labiana Health SA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LAB's stock price target?
Price Target
9.69 EUR

According to Wall Street analysts, the average 1-year price target for LAB is 9.69 EUR with a low forecast of 9.6 EUR and a high forecast of 9.98 EUR.

What is the Revenue forecast for Labiana Health SA?
Projected CAGR
10%

Over the last 6 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 10%.

What is the Operating Income forecast for Labiana Health SA?
Projected CAGR
23%

Over the last 6 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 2 years is 23%.

What is the Pre-Tax Income forecast for Labiana Health SA?
Projected CAGR
190%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 2 years is 190%.

What is the Net Income forecast for Labiana Health SA?
Projected CAGR
77%

Over the last 6 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 2 years is 77%.

Back to Top